Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors

Clinical trial NCT00084734 · COMPLETED

Trial details

NCT number: NCT00084734
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2002-05-01
Primary completion: 2009-11-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.